AG真人官方

Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient鈥檚 own biology for the treatment of rare diseases, today announced that Dirk Thye, M.D., Quince鈥檚 Chief Executive Officer and Chief Medical Officer, will participate at the H.C. Wainwright 27^th Annual Global Investment Conference. Access to the company鈥檚 presentation will be available on Friday, September 5, 2025 beginning at 7:00 a.m. Eastern Time.

A webcast of the presentation will be accessible on the Events page under the News & Events heading of Quince鈥檚 Investor Relations website at . An archive of the webcast will be available shortly following the end of the live event.

About Quince Therapeutics

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient鈥檚 own biology for the treatment of rare diseases. For more information on the company and its latest news, visit and follow Quince on social media platforms , , , and .

View source version on businesswire.com:

Media & Investor Contact:

Stacy Roughan

Quince Therapeutics, Inc.

Vice President, Corporate Communications & Investor Relations

[email protected]

Source: Quince Therapeutics, Inc.